Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion type Assertion NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_head.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion description "[Cost effectiveness of dabrafenib as a first-line treatment in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma in Canada.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_provenance.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion evidence source_evidence_literature NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_provenance.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion SIO_000772 25488880 NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_provenance.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion wasDerivedFrom befree-2016 NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_provenance.
- NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_assertion wasGeneratedBy ECO_0000203 NP1246321.RAORutWNciue-ivFyTQ3BfvxIXrm51-kIZ2yfYDp5OEDQ130_provenance.